Scientists Discover A Non-Invasive Treatment For Multiple Sclerosis

Views 29999

Multiple sclerosis (MS) is believed to be one of the most widespread and disabling neurological conditions in the world, with an estimated 2.3 million people suffering from the condition worldwide. The latest statistics estimate that there are currently 400,000 individuals suffering from MS in the US and a further 100,000 individuals in the UK.

What Is Multiple Sclerosis?

There is little known about the cause of MS, however, according to a leading MS website, it is not believed to be an inherited condition. They stated that:

“Researchers still aren’t certain what causes MS. One leading hypothesis is that it’s a genetic predisposition combined with an environmental or viral factor. People with other autoimmune diseases, especially type 1 diabetes, thyroid disease, or inflammatory bowel disease, are at a slightly increased risk of developing MS. Researchers are also studying the relationship between MS and infections such as Epstein-Barr, herpes, and varicella-zoster, among others. However, MS itself is not contagious.”

They continued:

1. Relapsing-remitting MS (RRMS) is characterized by clearly defined relapses of increased disease activity and worsening symptoms. These are followed by remissions in which the disease doesn’t progress. Symptoms may improve or disappear during remission. Approximately 85 percent of patients are diagnosed with RRMS at onset.

2. Untreated, about 50 percent of people with RRMS transition to secondary-progressive MS (SPMS) within a decade of the initial diagnosis.

3. Primary-progressive MS (PPMS) is diagnosed in about 10 percent of MS patients at onset. People with PPMS experience a steady progression of the disease with no clear relapses or remissions. The rate of PPMS is equally divided between men and women. Symptoms usually begin between the ages of 35 and 39.

4. Progressive-relapsing MS (PRMS) is the rarest form of MS, representing about 5 percent of MS patients. People with PRMS have clear relapses combined with a steady progression of the disease.

The symptoms of MS vary from person to person, however, according to Healthline, early symptoms of MS are:

  • fatigue
  • vision problems
  • tingling and numbness
  • vertigo and dizziness
  • muscle weakness and spasms
  • problems with balance and coordination

According to Healthline, there is currently no cure for MS, however, there are 12 FDA approved disease-modifying medications listed on their website.

Researchers Have Discovered an Alternative to Medication

Whilst medication can often alleviate the symptoms of MS, scientists and researchers from around the world have been questioning the effects that the use of long term-medication can have on the body.  

Scientists from Keele University in Staffordshire believe that they have found a less invasive treatment to alleviate the suffering of MS patients.

Professor Christopher Exley and his team have been studying a link between human exposure to aluminum and MS, ever since they discovered that like Alzheimer’s disease patients, many MS sufferers had an unusually high body burden of aluminium. In a paper titled A role for aluminium in multiple sclerosis, they wrote:

We showed that individuals with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) excreted significant amounts of aluminium in their urine (Exley et al., 2006). This, we thought, unexpected finding led us to speculate if aluminium could have a role to play in MS? One clue that it might be involved was the consistent observation in animal models of aluminium intoxication that myelin is a preferred target for aluminium in the brain. Since myelin breakdown is an important factor in the progression of MS in humans this led us to advance the hypothesis that human exposure to aluminium was playing a part in the disease.

The researchers stated:

“We designed a small clinical trial to further test our observation that individuals with MS have a high body burden of aluminium and we included in the trial a prospective therapeutic element. We had previously shown that regular drinking of a silicon-rich mineral water was an effective and non-invasive therapy for the removal of aluminium from the body.”

As the team had previously found that drinking a silicon-rich mineral water had helped reduce the body burden of aluminum in patients suffering from Alzheimer’s disease, the team began to question whether or not it would also be effective in helping to remove aluminium from the body of individuals with MS. However, there was just one problem; they stated that:

“Neither the research councils nor the MS charities in the United Kingdom were prepared to fund our trial so we approached Spritzer, a Malaysian mineral water company, and they along with Keele University’s ACORN scheme agreed to support the trial as part of a PhD.

We completed the trial towards the end of 2015 and the results are now reported in the journal EBioMedicine. The trial was run over 24 weeks. During the first 12 weeks (designated the control period) we simply measured urinary excretion of aluminium and silicon in 15 individuals with SPMS. We then continued these measurements for the following 12 weeks (designated the treatment period) during which time all individuals drank at least 1L of a silicon-rich mineral water (Spritzer) every day. The results of the trial are unequivocal both in demonstrating that individuals with MS have a high body burden of aluminium and in showing that regular drinking of Spritzer helped to remove aluminium from their body.”

Exley and his team concluded that:

While none of the participants suffered any relapses during the 24 weeks of the trial this period of time is too short to know if they benefitted from drinking the silicon-rich mineral water. However, we do now know that people with MS have too much aluminium in their bodies and therefore if aluminium is contributing to their disease then regular drinking of a silicon-rich mineral water could be a much-needed, simple, non-invasive and effective therapy for individuals with MS.

Please note that the silicon-rich mineral water, Spritzer, is sold as Acilis in the UK.

Acilis state on their website that:

Used in the clinical trials of scientists at Keele University, and available for UK and EU customers, ACILIS by Spritzer is a unique, natural silica bottled water drawn from deep within the Malaysian rainforests. Bottled at source and untouched by human hand, this artesian bottled water can help you to stay young, healthy and beautiful – on the inside and out – and proven to remove toxicity.

But that’s not all: Scientists at Keele University have discovered an extraordinary and unrivalled benefit to silica in its water-based form. This form of silica (orthosilicic acid, or OSA) is able to cross the gut wall and bind with aluminium particles in the blood, safely flushing them out and therefore performing an all-natural and non-invasive removal of aluminium. Removing aluminium from our bodies is a precautionary health measure we should all consider taking, after recent research has revealed a definitive link between aluminium accumulation and neurological conditions.”

Speaking on the subject of Exley’s recent research, Acilis stated that:

“Latest scientific research in the UK has found that drinking silica-rich water helps reduce high levels of neurotoxic aluminium in those suffering from the disabling neurological illness Multiple Sclerosis (MS).

View the weblink below into the research findings of scientists led by Professor Christopher Exley of Keele University, just published in the respected medical journal EBioMedicine.

*10% of all sales of Acilis by Spritzer in the UK with is donated towards further research at Keele University into the effects of drinking silica-rich water.”

Greenmedinfo found it shocking that Exley and his team were refused funding for such important research. With an estimated 2.5 million people suffering from MS worldwide, and around 200 people being diagnosed with the condition in the US every week, Exley’s findings could transform the lives of millions of people.

Maybe the UK research councils and MS charities that were approached by Exley refused to fund his unprecedented research because their loyalties lay not with the patient but with Big Pharma.

Interestingly, during a 2015 conference, the Big Pharma whistleblower, Dr. John Virapen hit the nail on the head when he stated that:

What is the pharma industry doing to us? They’re the most powerful industry in the world. They sleep in the same bed as government’s, they use corruption to get what they want. Corruption involves money, they have lots and lots and lots of money and that is how they make their money. Now, they also kill more people than the wars, we have in the world but long term they punish you and then they kill you. And that has to stop.

He continued:

They are not interested in curing any disease that you may have, they are more interested in making you get diseases. They are interested in symptomatic treatment, they want patients who are diabetic, cardiology patients, Parkinson’s disease, Rheumatoid arthritis, arthrosis because you live a long time and the drugs that you have to take, you take that for the rest of your life.

So let me ask you the question: Is there anybody in here that can tell me, when was the last time you heard or read that a pharma company has come with something that cures a disease? I will give you 100 euros right now if you tell me. They don’t cure anything they make you sick.

We believe that it was for the reasons outlined by Dr. Virapen in his conference that Professor Exley and his team were refused funding for their ground-breaking research.

For more information on the dangers of aluminum and the work of Professor Christopher Exley, see: Children’s Medical Safety Institute.

To order Acilis silicon-rich mineral water, please go to

For additional research on natural solutions for multiple sclerosis visit our database on the subject. 

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024, Journal Articles copyright of original owners, MeSH copyright NLM.